There is only one clinical trial for lixisenatide in PD, assessing its efficacy in slowing motor disability progression in early-stage patients over 12 months, followed by a 2-month washout period
We regularly check in with you to make sure you are getting the most out of your medication
In particular, poly(I:C), a synthetic viral RNA mimic, increased GLP-1 release in mice [1-2]
Mechanisms of Action and Therapeutic Rationale Physiological Basis of GLP-1 Action GLP-1, an incretin hormone, plays a crucial role in glucose metabolism and appetite regulation, influencing insulin secretion, insulin-sensitivity, and gastric emptying [15] [16]
This ensures consistent and harmonized BE standards for both IR and qualifying MR products
Illustration on this page were created with BioRender.com.